Announcement on Progress of Sale of Equity in Controlled Grand-Subsidiary and Completion of Industrial and Commercial Registration Change

Tianjin Chasesun Pharmaceutical Co., Ltd.·July 2, 2026·1 page

✨ AI Summary

Tianjin Red Sun Pharmaceutical Co., Ltd. announces the completion of the equity transfer registration for its controlled grand-subsidiary, Lianyungang Tiansheng Pharmaceutical Auxiliary Technology Co., Ltd. Following this, the company no longer holds control over Tiansheng Auxiliary, and it will be removed from the consolidated financial statements. Investors are advised to be aware of investment risks.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Tianjin Red Sun Pharmaceutical Co., Ltd.

CHASE SUN

Stock Code: 300026

Stock Abbreviation: Red Sun Pharmaceutical

Announcement No.: 2026-036

Announcement on Progress of Sale of Equity in Controlled Grand-Subsidiary and Completion of Industrial and Commercial Registration Change

The Company and all members of the Board of Directors guarantee the content of the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.

I. Transaction Overview

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.